Hohance Chemistry | Looshine (Shanghai) Pharmaceutical Technology Co., Ltd

Looshine (Shanghai) Pharmaceutical Technology Co., Ltd. has been certified as a high-tech enterprise

2022-3-18 14:17:06 265

At the beginning of the 2022 new year, when everything recovers and flowers bloom in spring, Looshine (Shanghai) Pharmaceutical Technology Co., Ltd. welcomes a good news - according to the provisions of the "Measures for the Administration of the recognition of High-tech Enterprises" and the "Guidelines for the Administration of the Recognition of High-tech Enterprises", the office of the Shanghai high-tech enterprise recognition management working group organized expert review and identified Looshine (Shanghai) Pharmaceutical Technology Co., Ltd. as a high-tech enterprise.

The recognition of high-tech enterprises is a comprehensive evaluation and recognition of the company's core independent intellectual property rights, the transformation ability of scientific and technological achievements, the organization and management level of research and development, growth indicators and talent structure. It needs to be screened at all levels and the review is quite strict. The final recognition of our company shows that the company has received strong support and recognition from the state in innovation and R & D. at the same time, it has actively promoted the process of independent innovation and independent R & D.

Looshine has been adhering to the core concept of "building an enterprise with technology and paying attention to innovation", always taking technology as the first driving force of development, constantly pursuing excellence and continuously improving the ability of independent innovation. Being rated as a high-tech enterprise this time will further promote the process of independent innovation and independent research and development of the company, and it is also another milestone in the development history of the company. In the future, our company will continue to introduce a high-quality talent team to provide a fundamental guarantee for independent innovation. Pay more attention to independent innovation, protect intellectual property rights and enhance the core strength of enterprises. Continue to increase investment in scientific research and enrich the stamina of enterprise innovation and development. To provide strong support for the sustainable development of CDMO.